Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
Authors
Keywords
-
Journal
npj Precision Oncology
Volume 5, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-12
DOI
10.1038/s41698-021-00168-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fully synthetic matrices for in vitro culture of primary human intestinal enteroids and endometrial organoids
- (2020) Victor Hernandez-Gordillo et al. BIOMATERIALS
- Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers
- (2020) Myriam Chalabi et al. NATURE MEDICINE
- The evidence landscape in precision medicine
- (2020) Spencer Phillips Hey et al. Science Translational Medicine
- Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment
- (2020) Joe T. Sharick et al. Frontiers in Oncology
- Mechano-modulatory synthetic niches for liver organoid derivation
- (2020) Giovanni Sorrentino et al. Nature Communications
- Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses
- (2020) Chris Jenske de Witte et al. Cell Reports
- Next-Generation Surrogate Wnts Support Organoid Growth and Deconvolute Frizzled Pleiotropy In Vivo
- (2020) Yi Miao et al. Cell Stem Cell
- Establishment of patient-derived cancer organoids for drug-screening applications
- (2020) Else Driehuis et al. Nature Protocols
- Organoids — Preclinical Models of Human Disease
- (2019) Mo Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity
- (2019) Oded Kopper et al. NATURE MEDICINE
- Intratumoral Heterogeneity: More Than Just Mutations
- (2019) Kunihiko Hinohara et al. TRENDS IN CELL BIOLOGY
- Oral mucosal organoids as a potential platform for personalized cancer therapy
- (2019) Else Driehuis et al. Cancer Discovery
- Mechanically and chemically defined hydrogel matrices for patient-derived colorectal tumor organoid culture
- (2019) Shengyong Ng et al. BIOMATERIALS
- The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs
- (2019) D. L. van der Velden et al. NATURE
- Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer
- (2019) Ye Yao et al. Cell Stem Cell
- A rectal cancer organoid platform to study individual responses to chemoradiation
- (2019) Karuna Ganesh et al. NATURE MEDICINE
- Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
- (2019) Salo N. Ooft et al. Science Translational Medicine
- Model of Patient-Specific Immune-Enhanced Organoids for Immunotherapy Screening: Feasibility Study
- (2019) Konstantinos I. Votanopoulos et al. ANNALS OF SURGICAL ONCOLOGY
- A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity
- (2019) Fadi Jacob et al. CELL
- A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
- (2018) Norman Sachs et al. CELL
- Organoids
- (2018) Natalie de Souza NATURE METHODS
- Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
- (2018) Georgios Vlachogiannis et al. SCIENCE
- Organoid profiling identifies common responders to chemotherapy in pancreatic cancer
- (2018) Hervé Tiriac et al. Cancer Discovery
- In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening
- (2018) Andrea R. Mazzocchi et al. Scientific Reports
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
- (2018) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics
- (2018) Xiaodun Li et al. Nature Communications
- Functional precision cancer medicine—moving beyond pure genomics
- (2017) Anthony Letai NATURE MEDICINE
- Designer matrices for intestinal stem cell and organoid culture
- (2016) Nikolce Gjorevski et al. NATURE
- The role of tumor microenvironment in therapeutic resistance
- (2016) Beomseok Son et al. Oncotarget
- Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening
- (2016) Carla S Verissimo et al. eLife
- Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
- (2015) Marc van de Wetering et al. CELL
- Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials
- (2015) Funda Meric-Bernstam et al. JOURNAL OF CLINICAL ONCOLOGY
- Statistical and Practical Considerations for Clinical Evaluation of Predictive Biomarkers
- (2013) M.-Y. C. Polley et al. JNCI-Journal of the National Cancer Institute
- Metrics other than potency reveal systematic variation in responses to cancer drugs
- (2013) Mohammad Fallahi-Sichani et al. Nature Chemical Biology
- Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
- (2012) Douglas G Altman et al. BMC Medicine
- Comparing Statistical Methods for Quantifying Drug Sensitivity Based on In Vitro Dose–Response Assays
- (2011) Shuguang Huang et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
- (2011) Toshiro Sato et al. GASTROENTEROLOGY
- Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology
- (2009) Richard Simon Personalized Medicine
- The cancer biomarker problem
- (2008) Charles L. Sawyers NATURE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started